An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Stopped Explanation will be submitted later.

Conditions

• SARS-CoV-2 Infection
• COVID-19
• Moderate and Severe COVID-19

Interventions

• OTHER: Standard of Care (SoC)
• DRUG: Remdesivir

Sponsor

Professor Dr. Bernd Mühlbauer

Collaborators

• [object Object]
• [object Object]